HPC embraces new technologies, which promise to reveal unprecedented insights into biological systems, during normal development, homeostasis and disease. Our approaches include high-resolution-imaging, single cell multi-omics, microfluidic-, ‘organ on chip’, nano-scale interactions and atomic resolution cryo-EM to accurately quantify biological systems in health in disease. Overall, HPC technologies are geared towards novel solutions that improve personalised prevention and inform new diagnostics and therapies.
HPC Principal Investigators are outstanding scientists with a proven track record in their respective fields and the ambition to make a difference in biomedicine, harnessing engineering and informatics tools. They are interdisciplinary by nature, highly collaborative, and committed to drive a globally competitive research program.